Latest AKRO reports update at 2024-02-29: 202320222021
Akero Therapeutics logo
Akero Therapeutics AKRO
$ 20.8 -1.05%

Akero Therapeutics ROE Ratio 2011-2024 | AKRO

Annual ROE Ratio Akero Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-28.35 -34.31 -59.59 -30.62 -33.99 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-28.35 -59.59 -37.37

Quarterly ROE Ratio Akero Therapeutics

2023-Q3 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-35.93 -47.59 -46.58 -58.83 -60.73 -55.4 -31.53 -62.14 -80.51 -97.98 -91.85 -125.84 -129.21 -132.59 -101.97 -79.64 -23.32 73.85 93.95 93.95 71.62 8.45 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
93.95 -132.59 -41.81